Gut dysbiosis in Alzheimer's disease reduces butyrate-producing bacteria (Faecalibacterium prausnitzii, Roseburia intestinalis), causing systemic butyrate deficiency. Butyrate normally acts as an endogenous histone deacetylase (HDAC) inhibitor; decreased butyrate allows HDAC2 to suppress histone acetylation at promoters of anti-inflammatory genes in microglia, impairing their ability to phagocytose and clear amyloid-beta plaques. This HDAC2-mediated epigenetic silencing reduces expression of gen
Genetically engineered probiotics producing specific short-chain fatty acids like butyrate and propionate can selectively reprogram microglial activation from pro-inflammatory M1 to neuroprotective M2 phenotype, reducing Aβ-induced neuroinflammation while enhancing microglial clearance of amyloid plaques.
Debate provenance: derived from debate `sess_gut-brain-ad` on question: Gut-Brain Axis Therapeutics for Alzheimer's Disease?. Consensus signal: domain_expert, skeptic, synthesizer, theorist di
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
EngineeredEpigenetic Transcriptional
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
4/11
dimensions won
Gut butyrate deficiency impairs microgli
1/11
dimensions won
Selective Microglial Reprogramming via E
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.74
0.60
Evidence
0.68
0.55
Novelty
0.72
0.60
Feasibility
0.78
0.00
Impact
0.00
0.00
Druggability
0.00
0.00
Safety
0.00
0.00
Competition
0.00
0.00
Data
0.00
0.00
Reproducible
0.00
0.00
KG Connect
0.24
0.54
Score Breakdown
Dimension
Gut butyrate deficiency impair
Selective Microglial Reprogram
Mechanistic
0.740
0.600
Evidence
0.680
0.550
Novelty
0.720
0.600
Feasibility
0.780
0.000
Impact
0.000
0.000
Druggability
0.000
0.000
Safety
0.000
0.000
Competition
0.000
0.000
Data
0.000
0.000
Reproducible
0.000
0.000
KG Connect
0.235
0.540
Evidence
Gut butyrate deficiency impairs microglial amyloid clearance
No evidence citations yet
Selective Microglial Reprogramming via Engineered Probiotic
No evidence citations yet
Debate Excerpts
Gut butyrate deficiency impairs microglial amyloid
4 rounds · quality: 0.94
Persona-Theorist
Based on the provided literature, I'll generate novel therapeutic hypotheses targeting the gut-brain axis for Alzheimer's disease. The evidence shows clear mechanistic connections between gut microbio...
Persona-Skeptic
I'll provide a rigorous critique of each hypothesis, identifying weaknesses and providing revised confidence scores based on the available evidence.
## HYPOTHESIS 1: Selective Microglial Reprogrammin...
Persona-Domain Expert
Based on my analysis of the hypotheses and the provided literature, I'll assess the practical feasibility of the surviving hypotheses that show some promise. Most of the original hypotheses face funda...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "Gut Barrier Restoration to Prevent Bacterial Translocation and Systemic Inflammation",
"description": "Targeted therapy using specific mu...
Selective Microglial Reprogramming via Engineered
4 rounds · quality: 0.94
Persona-Theorist
Based on the provided literature, I'll generate novel therapeutic hypotheses targeting the gut-brain axis for Alzheimer's disease. The evidence shows clear mechanistic connections between gut microbio...
Persona-Skeptic
I'll provide a rigorous critique of each hypothesis, identifying weaknesses and providing revised confidence scores based on the available evidence.
## HYPOTHESIS 1: Selective Microglial Reprogrammin...
Persona-Domain Expert
Based on my analysis of the hypotheses and the provided literature, I'll assess the practical feasibility of the surviving hypotheses that show some promise. Most of the original hypotheses face funda...
Persona-Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "Gut Barrier Restoration to Prevent Bacterial Translocation and Systemic Inflammation",
"description": "Targeted therapy using specific mu...